Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-014941
Filing Date
2025-06-12
Accepted
2025-06-12 19:30:37
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3985
  Complete submission text file 0001641172-25-014941.txt   5534
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1651 NORTH BEVERLY DRIVE BEVERLY HILLS CA 90210
Business Address
Niklas Victoria Ninon Olivia (Reporting) CIK: 0002012250 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41934 | Film No.: 251044361